Skip to main content
Contact Us
Sign Up
Subscriber Sign In
English
日本語
navigation
Search
COVID-19
COVID-19 Partnering Event
COVID-19 Update
COVID-19 EventAnalyzer
Evaluate Vantage COVID-19 Report
COVID-19 Stories from Evaluate Vantage
Evaluate’s Business Continuity Plan
What We Do
Commercial Intelligence
Products
EvaluatePharma
EvaluatePharma Vision
Japan Drug Forecasts
European Drug Forecasts
Epi Analyzer
Evaluate Custom Solutions
Evaluate Vantage
News
Analysis
Policy & Pricing
Data Insights
Events
Medtech
Therapy Areas
Editorial Team
About Evaluate Vantage
How We Can Help You
Pharma and Biotech
Medtech
Financial Services
Management Consultancies
Service Providers
Customer Testimonials
Thought Leadership
English
日本語
About Us
Press Releases
Media Coverage
Executive Team
Vision & History
Careers
Current Vacancies
Contact Us
Sign Up for Evaluate Vantage
Subscriber Sign In
Search
Open configuration options
Search
Vantage
Covid-19
Covid-19 Coverage
Evaluate Vantage COVID-19 Report
News
Snippets
Deals
Trial results
Patents and litigation
Corporate strategy
Analysis
Interviews
Spotlight
Vantage points
Vantage views
Data Insights
M&A
IPO
NME approvals
Quarterly shareprice performance
Venture financing
Vantage data points
Other data
Events
Company events
Conferences
Upcoming events
Medtech
Therapy Areas
About
Editorial team
ARYx Therapeutics
January 07, 2011
Comeback stories drive small cap risers in 2010
October 21, 2010
Partnering opportunities abound in oncology, CNS and infectious diseases
October 05, 2010
Steady growth the theme for small cap risers after nine months
July 02, 2010
Mixed bag of small cap winners and losers in first half
April 06, 2010
InterMune tops small cap gainers once more in first quarter
February 22, 2010
Broken promises force ARYx to assess strategic options
August 12, 2009
Cumberland cracks open IPO window
July 09, 2009
ARYx under pressure to deliver deals as promised
August 18, 2008
ARYx still walking a tightrope
July 04, 2008
ARYx seeking knight in shining armour
We use cookies on this website. By using this site, you agree that we may store and access cookies on your device.
Find out more.
OK
Independent, data-driven daily news and analysis on pharma, biotech and medtech.
Sign up
Latest Reports
April 16, 2020
Evaluate Vantage COVID-19 Report
February 20, 2020
Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review
Editor's Picks
April 22, 2020
Covid-19 antibody tests face a very specific problem
April 23, 2020
Covid-19’s clinical damage starts to emerge
April 23, 2020
The crucial data readouts coming soon for small biotechs
April 22, 2020
AACR 2020 preview – no Tigit, but plenty of novel mechanisms
April 03, 2020
The long path to an effective coronavirus vaccine
